Constitutive expression of a chimeric receptor that delivers IL-2/IL-15 signals allows antigen-independent proliferation of CD8+CD44(high) but not other T cells

Journal of Immunology

Volumn 164, Issue 11, 2000, Pages 5659-5667

  Gasser, Stephan ^a   Corthésy, Patricia ^a   Beerman, Friedrich ^a   MacDonald, H Robson ^b   Nabholz, Markus ^a  

^a SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 15; INTERLEUKIN 2; RECEPTOR;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; CHIMERA; CONTROLLED STUDY; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; T LYMPHOCYTE; TRANSGENIC MOUSE;

EID: 0342748479     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.11.5659     Document Type: Article

References (36)

1. DiSanto, J. P. 1997. Cytokines: shared receptors, distinct functions. Curr. Biol. 7:R424.
2. Leonard, W. J. 1996. The molecular basis of X-linked severe combined immunodeficiency: defective cytokine receptor signaling. Annu. Rev. Med. 47:229.
3. Boise, L. H., A. J. Minn, C. H. June, T. Lindsten, and C. B. Thompson. 1995. Growth factors can enhance lymphocyte survival without committing the cell to undergo cell division. Proc. Natl. Acad. Sci. USA 92:5491.
4. Gonzalez-Garcia, A., I. Merida, A. C. Martinez, and A. C. Carrera. 1997. Intermediate affinity interleukin-2 receptor mediates survival via a phosphatidylinositol 3-kinase-dependent pathway. J. Biol. Chem. 272:10220.
5. Unutmaz, D., F. Baldoni, and S. Abrignani. 1995. Human naive T cells activated by cytokines differentiate into a split phenotype with functional features intermediate between naive and memory T cells. Int. Immunol. 7:1417.
6. Hattori, M., H. Okazaki, Y. Ishida, M. Onuma, S. Kano, T. Honjo, and N. Minato. 1990. Expression of murine IL-2 receptor β-chain on thymic and splenic lymphocyte subpopulations as revealed by the IL-2-induced proliferative response in human IL-2 receptor α-chain transgenic mice. J. Immunol. 144:3809.
7. Nishi, M., Y. Ishida, and T. Honjo. 1988. Expression of functional interleukin-2 receptors in human light chain/Tac transgenic mice. Nature 331:267.
8. + T cells in vivo by IL-15. Immunity 8:591.
9. Izuhara, K., A. Miyajima, and N. Harada. 1993. The chimeric receptor between interleukin-2 receptor β chain and interleukin-4 receptor transduces interleukin-2 signal. Biochem. Biophys. Res. Commun. 190:992.
10. Zhumabekov, T., P. Corbella, M. Tolaini, and D. Kioussis. 1995. Improved version of a human CD2 minigene based vector for T cell-specific expression in transgenic mice. J. Immunol. Methods 185:133.
11. Ryan, J. J., L. J. McReynolds, A. Keegan, L. H. Wang, E. Garfein, P. Rothman, K. Nelms, and W. E. Paul. 1996. Growth and gene expression are predominantly controlled by distinct regions of the human IL-4 receptor. Immunity 4:123.
12. Hatakeyama, M., M. Tsudo, S. Minamoto, T. Kono, T. Doi, T. Miyata, M. Miyasaka, and T. Taniguchi. 1989. Interleukin-2 receptor β chain gene: generation of three receptor forms by cloned human α and β chain cDNA's. Science 244:551.
13. Ho, S. N., H. D. Hunt, R. M. Horton, J. K. Pullen, and L. R. Pease. 1989. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51.
14. Beermann, F., E. Hummler, E. Schmid, and G. Schutz. 1993. Perinatal activation of a tyrosine aminotransferase fusion gene does not occur in albino lethal mice. Mech. Dev. 42:59.
15. Hogan, B., F. Costantini, and E. Lacy. 1986. Manipulating the Mouse Embryo: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
16. Lowenthal, J. W., P. Corthesy, C. Tougne, R. Lees, H. R. MacDonald, and M. Nabholz. 1985. High and low affinity IL 2 receptors: analysis by IL 2 dissociation rate and reactivity with monoclonal anti-receptor antibody PC61. J. Immunnl. 135:3988.
17. Lyons, A. B., and C. R. Parish. 1994. Determination of lymphocyte division by flow cytometry. J. Immunol. Methods 171:131.
18. Zurawski, S. M., T. R. Mosmann, M. Benedik, and G. Zurawski. 1986. Alterations in the amino-terminal third of mouse interleukin 2: effects on biological activity and immunoreaclivity. J. Immunol. 137:3354.
19. Moreau, J. L., M. Nabholz, T. Diamantstein, T. Malek, E. Shevach, and J. Theze. 1987. Monoclonal antibodies identify three epitope clusters on the mouse p55 subunit of the interleukin 2 receptor: relationship to the interleukin 2-binding site. Eur. J. Immunol. 17:929.
20. Taswell, C. 1981. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J. Immunol. 126:1614.
21. Soldaini, E., H. R. MacDonald, and M. Nabholz. 1992. Minimal growth requirements of mature T lymphocytes: interleukin (IL)-1 and IL-6 increase growth rate but not plating efficiency of CD4 cells stimulated with anti-CD3 and IL-2. Eur. J. Immunol. 22:1707.
22. Soldaini, E., M. Pla, F. Beermann, E. Espel, P. Corthesy, S. Barange, G. A. Waanders, H. R. MacDonald, and M. Nabholz. 1995. Mouse interleukin-2 receptor alpha gene expression: delimitation of cis-acting regulatory elements in transgenic mice and by mapping of DNase-I hypersensitive sites. J. Biol. Chem. 270:10733.
23. Cerottini, J. C., and H. R. MacDonald. 1981. Limiting dilution analysis of alloantigen-reactive T lymphocytes. V. Lyt phenotype of cytolytic T lymphocyte precursors reactive against normal and mutant H-2 antigens. J. Immunol. 126: 490.
24. Ryser, J. E., and H. R. MacDonald. 1979. Limiting dilution analysis of alloantigen-reactive T lymphocytes. III. Effect of priming on precursor frequencies. J. Immunol. 123:128.
25. Budd, R. C., J. C. Cerottini, C. Horvath, C. Bron, T. Pedrazzini, R. C. Howe, and H. R. MacDonald. 1987. Distinction of virgin and memory T lymphocytes: stable acquisition of the Pgp-1 glycoprolein concomitant with antigenic stimulation. J. Immunol. 138:3120.
26. Oehen, S., and K. Brduscha-Riem. 1998. Differentiation of naive CTL to effector and memory CTL: correlation of effector function with phenotype and cell division. J. Immunol. 161:5338.
27. Kondo, M., Y. Ohashi, K. Tada, M. Nakamura, and K. Sugamura. 1994. Expression of the mouse interleukin-2 receptor γ chair in various cell populations of the thymus and spleen. Eur. J. Immunol. 24:2026.
28. + T cells of human IL-2 receptor β-chain transgenic mice. J. Immunol. 153:5373.
29. Asao, H., N. Tanaka, N. Ishii, M. Higuchi, T. Takeshita, M. Nakamura, T. Shirasawa, and K. Sugamura. 1994. Interleukin 2-induced activation of JAK3: possible involvement in signal transduction for c-Myc induction and cell proliferation. FEBS Lett. 351:201.
30. Crabtree, G. R. 1989. Contingent genetic regulatory events in T lymphocyte activation. Science 243:355.
31. Kawamura, M., D. W. McVicar, J. A. Johnston, T. B. Blake, Y. Q. Chen, B. K. Lal, A. R. Lloyd, D. J. Kelvin, J. E. Staples, J. R. Ortaldo, et al. 1994. Molecular cloning of L-JAK, a Janus family protein-tyrosine kinase expressed in natural killer cells and activated leukocytes. Proc. Natl. Acad. Sci. USA 91:6374.
32. Takeshita, T., K. Ohtani, H. Asao, S. Kumaki, M. Nakamura, and K. Sugamura. 1992. An associated molecule, p64, with IL-2 receptor β chain: its possible involvement in the formation of the functional intermediate-affinity IL-2 receptor complex. J. Immunol. 148:2154.
33. Swain, S. L., and L. M. Bradley. 1992. Helper T cell memory: more questions than answers. Semin. Immunol. 4:59.
34. Tolg, C., M. Hofmann, P. Herrlich, and H. Ponta. 1993. Splicing choice from ten variant exons establishes CD44 variability. Nucleic Acids Res. 21:1225.
35. Trowbridge, I. S., J. Lesley, R. Schulte, R. Hyman, and J. Trotter. 1982. Biochemical characterization and cellular distribution of a polymorphic, murine cell-surface glycoprotein expressed on lymphoid tissues. Immunogenetics 15:299.
36. Romero, P., P. R. Dunbar, D. Valmori, M. Pittet, G. S. Ogg, D. Rimoldi, J. L. Chen, D. Lienard, J. C. Cerottini, and V. Cerundolo. 1998. Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes. J. Exp. Med. 188:1641.